TheraVet SA
ALVET | BR
Overview
Corporate Details
- ISIN(s):
- BE0974387194
- LEI:
- 984500804EBR3F1EFF71
- Country:
- Belgium
- Address:
- Avenue Jean Mermoz 32, 6041 Charleroi
- Website:
- https://www.egeiro.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
TheraVet is a vet biotech company headquartered in Belgium (Jumet, Wallonia) with an US-based subsidiary. TheraVet's mission is to develop innovative, safe and effective treatments to improve the well-being and quality of life of companion animals suffering from osteoarticular diseases. TheraVet's main targets (indications & applications) are osteoarthritis, ligament & tendon injuries and bone surgery in cats and dogs as well as horses. TheraVet works in close collaboration with key opinion leaders in Belgium and abroad (France, Switzerland, United Kingdom & United States) to better address the ever-increasing needs of veterinary medicine.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-07 19:57 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 197.8 KB | ||
| 2025-03-07 19:57 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 197.8 KB | ||
| 2025-03-07 00:00 |
Legal Proceedings Report
20250307CA _EGEIRO CP eng.pdf
|
English | 183.2 KB | ||
| 2025-03-07 00:00 |
Legal Proceedings Report
20250307 CA_EGEIRO CP.pdf
|
French | 187.0 KB | ||
| 2025-01-27 00:00 |
M&A Activity
CP 20250127 EURONEXT qualification apport actif H4 acquisition inversée.pdf
|
French | 644.6 KB | ||
| 2025-01-27 00:00 |
Regulatory News Service
CP 20250127 EURONEXT qualification apport actif H4 acquisition inversée.pdf
|
French | 644.6 KB | ||
| 2024-12-12 18:00 |
Major Shareholding Notification
Informations privilégiées / Autres communiqués
|
French | 193.7 KB | ||
| 2024-12-12 00:00 |
Major Shareholding Notification
CP_EGEIRO-121224_notification_de_transparence_ARTICLE 14.pdf
|
French | 193.7 KB | ||
| 2024-12-05 18:00 |
Share Issue/Capital Change
Informations privilégiées / Autres communiqués
|
French | 182.9 KB | ||
| 2024-11-18 18:00 |
Board/Management Information
Inside Information / Other news releases
|
English | 191.3 KB | ||
| 2024-11-18 18:00 |
Board/Management Information
Informations privilégiées / Autres communiqués
|
French | 165.7 KB | ||
| 2024-11-18 00:00 |
Board/Management Information
EGEIRO-181124_CP démission EB.pdf
|
French | 165.7 KB | ||
| 2024-10-29 07:30 |
Post-Annual General Meeting Information
Inside Information / Other news releases
|
English | 257.0 KB | ||
| 2024-10-29 07:30 |
Post-Annual General Meeting Information
Informations privilégiées / Autres communiqués
|
French | 287.8 KB | ||
| 2024-10-28 07:30 |
Post-Annual General Meeting Information
CP_TheraVet_AG_FR.pdf
|
French | 268.3 KB |
Automate Your Workflow. Get a real-time feed of all TheraVet SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for TheraVet SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for TheraVet SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-11-21 | Bastianelli Enrico | Board | Other | 200,000 | 380,000.00 EUR |
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
